Equity Research Report

Stockisy Technical Analysis Crash Course in Hindi

Stockisy Technical Analysis Crash Course in Hindi – Learn to Understand Stock Charts Learn Candlestick Analysis, Chart Trends & Support-Resistance in Hindi | Launch Offer: ₹149 Course Overview – Technical Analysis...

MIDHANI Share Analysis: Profit Growth 18%, ₹2,290 Crore Order Book & 167 Days Receivables

MIDHANI Share Analysis: Profit Growth, Defence Orders aur 167 Days Receivables – FY26 Annual Report Mishra Dhatu Nigam Limited...

Cochin Shipyard Share Analysis: Business Model, Financial Results, Order Book aur Risk Factors

Cochin Shipyard Limited: Company Overview Cochin Shipyard Limited India ki ek important shipbuilding aur ship repair company hai. Company...

Paras Defence Share Analysis: Revenue ka 76% Trade Receivables

Paras Defence Share Analysis: Bade Defence Orders, Semiconductor Project aur Trade Receivables ka Sawal Paras Defence & Space Technologies...

Sindhu Trade Links Share Analysis: Business Model, ₹922 Crore Deal aur Dilution Risk

Sindhu Trade Links ka Business Model kya hai? Sindhu Trade Links Ltd ka business model multiple industries mein spread...
spot_img

Gufic Biosciences Profile: Leading Lyophilized Injection Manufacturer in India

Gufic Biosciences Limited (GBL) is a prominent global pharmaceutical company offering a wide spectrum of pharmaceutical products and services. Backed by a strong distribution...

Infrastructure: The Backbone of India’s $5 Trillion Economy Ambition

Infrastructure has always been regarded as the backbone of economic progress. For India, it is not just a sector—it is the foundation upon which...

Piramal Pharma: A Re-Emerging Pharma Player with Strong Growth Ambitions

Piramal Pharma Limited (PPL), a part of the Piramal Group, operates across three key segments: Contract Development and Manufacturing Organization (CDMO), Complex Hospital Generics (Critical Care),...

Cement Sector Consolidation: Ambuja Acquires Majority Stake in Orient Cement

Ambuja Cements has acquired a 37.8% stake in Orient Cement, marking a significant consolidation move in the Indian cement industry. The acquisition was executed through...

Mankind Pharma Levels Up: ₹12,000 Cr Revenue, ₹8,500 Cr Debt – What’s the Strategy?

Mankind Pharma has crossed a market capitalization of ₹1.05 lakh crore. The company continues to post consistent sales growth, and its EBITDA margins have...

Sectoral Breakouts: The Next Leaders of This Bull Market!

📊 Sectoral Breakout Alert!Several key sectors in the Indian stock market are showing signs of strong bullish momentum. Chart patterns and rising volumes suggest...
spot_img
WhatsApp chat